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PANEL I: Cross-Licensing and 
Injunctions—the Interplay 
Between Big Business, Small 
Business, and Non-
Practicing Inventors 
Moderator: Katherine Strandburg* 
Panelists: Lisa M. Ferri† 
 John M. Griem, Jr.‡ 
 Jonathan Putnam§ 
 MR. CAREY: Thank you all for being here.  For those of 
you reading a transcript of the day’s affairs in the Fordham 
Intellectual Property, Media & Entertainment Law Journal—the 
IPLJ, as we like to call it—congratulations on making a most 
excellent reading selection. 
 I am Erich Carey, the Editor-in-Chief of Volume XIX of the 
IPLJ, and it is my distinct privilege to welcome you all to our fall 
Symposium entitled “New Developments in IP: Strategies for Big 
and Small Business.” 
Today’s event marks the culmination of many months of 
discussion, planning, and preparation.  Before we begin our 
proceedings, a round of thanks is most certainly in order. 
First and foremost, I would like to thank the IPLJ’s 
Symposium editor, Mr. Anthony Rizzo, for his vision and 
A PDF version of this Article is available online at http://iplj.net/blog/archives/ 
volumexix/book4.  Visit http://iplj.net/blog/archives for access to the IPLJ archive. 
*  Professor, DePaul University College of Law. 
†  Partner, McDermott, Will & Emery, LLP. 
‡  Partner, Milbank, Tweed, Hadley & McCloy, LLP. 
§  CRA International. 
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dedication in organizing today’s event.  Today Anthony will be 
buzzing about the law school, making sure our program runs 
smoothly.  Nonetheless, when you see him, please take a minute to 
personally congratulate Anthony on a tremendous effort in 
bringing the day’s lineup together. 
Thanks, Anthony. 
Furthermore, both Anthony and the IPLJ have been most 
fortunate to have the assistance of Fordham Law School’s Office 
of Public Programming and Continuing Legal Education in 
planning our event.  From that office, we would like to thank and 
recognize David Quiles, Alice Wong, and, most especially, Helen 
Herman for all their time and effort in helping us achieve all of our 
goals for the Symposium. 
Helen is not here right now, but if the journal were in the 
business of giving out honorary memberships, she would have a 
place high on our masthead.  We would like to thank her so kindly 
for her patience and support in dealing with the IPLJ this year. 
The IPLJ, moreover, is, of course, a direct beneficiary of the 
distinguished intellectual property faculty at Fordham Law School.  
Most especially, we would like to thank the inimitable Professor 
Hugh Hansen, who will be here later this afternoon, who has been 
instrumental in helping us to select and recruit the talent for this 
year’s Symposium—and for, of course, keeping me on my toes in 
copyright class all the meanwhile. 
Furthermore, the IPLJ would like to acknowledge its gratitude 
to our most excellent panelists and moderators for traveling to be 
with us here this morning.  We have a tremendous lineup 
assembled.  Truly, our panelists and moderators are the centerpiece 
of today’s event.  We look forward to our discussions and have no 
doubt that they will be wide-ranging, insightful, informative, and, 
yes, citation-worthy. 
Finally, I would like to recognize and thank all the IPLJ’s 
editors and staff who, at the end of the day, really make the IPLJ 
the unique institution that it is.  For students at Fordham with a 
passion for IP law, the IPLJ is home.  The journal affords its 
members an unrivaled opportunity to learn, study, and contribute 
to the dialogue on all issues of intellectual property law.  Towards 
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those ends, the IPLJ team produces four books of scholarship each 
year. 
We are deep in the midst of publishing the IPLJ’s nineteenth 
volume, which features articles on a wide range of topics.  From 
the current state of defamation law to technology transfer, to the 
impact of the IP monopoly on voting rights, we are, of course, as 
proud as ever of our content this year. 
An electronic version of our upcoming first book, Volume 
XIX, may be presently found on our Web site at www.iplj.net.  We 
also have copies of some of last year’s issues available outside in 
the atrium, which you may help yourself to.  But when so doing, 
please consider subscribing to or sponsoring the IPLJ. 
Authors, we, of course, are always grateful to consider your 
submissions. 
I encourage you also to reach out to our journal members 
today, easily identifiable by their nametags, and learn more about 
the IPLJ or perhaps visit our journal office downstairs, where 
preparation will be under way for a first-ever IPLJ Thanksgiving, 
to take place on the conclusion of our Symposium this afternoon.  
It’s a distinct spirit that defines the IPLJ, and we try to bring that 
spirit to all that we do. 
Today we add another exciting chapter to the legacy of the 
IPLJ with this year’s installment of our annual fall Symposium.  
Today’s Symposium proposes to look at how recent developments 
in key areas of intellectual property law stand to affect both 
business and litigation strategy. 
Our panels were constructed carefully to try to shed some light 
on big and small business concerns. We will begin the morning 
with our patent panel, which proposes to look at the evolving role 
of injunctions in patent litigation in the wake of the United States 
Supreme Court’s decision in eBay v. MercExchange.  Following 
our patent discussion, we will feature our copyright panel, which 
will examine the availability of statutory damages and suits for 
infringement, as well as the viability of the controversial “making 
available” right.  After our copyright panel, we will break for lunch 
and ultimately conclude our Symposium with our trademark panel, 
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which aims to take the pulse of the current status of the trademark 
doctrine of dilution. 
It should be a fantastic day of scholarship. I would encourage 
everyone to stay and attend all three panels today. 
As I alluded to earlier, transcripts of today’s panels will be 
published in our final book of the year, which is due out this 
summer. 
To formally begin our event, I would like to introduce our 
faculty moderator, Professor Mark Patterson.  This is Professor 
Patterson’s first year as our moderator.  We are ever so grateful 
that he agreed to join us on the IPLJ. 
Professor Patterson brings to the journal his experience both as 
a widely published author and revered professor at Fordham Law 
in the areas of contract, antitrust, and patent law.  Consistent with 
his background, we asked Professor Patterson to give a few 
introductory remarks and then introduce our patent panel 
moderator. 
Now that the coffee is hopefully starting to kick in, please give 
a hand in welcoming Professor Patterson.  Thank you all very 
much. 
PROF. PATTERSON: Thank you, Erich. 
On behalf of the law school and its faculty and administration, 
I welcome you all here to this year’s IPLJ Symposium.  
Unfortunately, Dean Treanor couldn’t be here this morning, but I 
know that he is excited about having this terrific event here at the 
law school today.  As many of you know, Dean Treanor views 
intellectual property and information law more generally as a 
strength of Fordham and an area that he actually wants to make 
even stronger. 
As Erich said, this is my first year as moderator of the IPLJ.  
But I can say that, as moderator and as a previous participant in the 
Symposium, I’m proud to be associated with the journal. As Erich 
said, Anthony Rizzo, the Symposium Editor this year, and the 
other members of the journal put in a lot of time and devote a great 
deal of effort to the Symposium, both planning and leading up to it 
and in publishing the Symposium subsequently.  They do that great 
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work not just on the Symposium, but, of course, on the work of the 
journal more generally, which is why it’s one of the most highly 
rated journals in this area. 
So I encourage you, if you have articles in this area that you 
would like to publish, to submit them to the journal. 
I also want to acknowledge the Fordham faculty who are 
involved here today.  As Erich said, Hugh Hansen, who will be 
here later, has been heavily involved in the planning of the 
program.  Our visiting professor, Kathy Strandburg, is moderating 
the patent panel, and we have two adjunct faculty participating on 
the panels today, Lisa Ferri, who is on the first panel here, who 
teaches patent litigation at the school, and Eric Prager, who is on 
the trademark panel later on this afternoon. 
Finally, I want to say just a little bit about the Symposium’s 
focus.  I think it’s a really commendable focus on looking past the 
basic idea of IP or even its components—patent, copyright, and 
trademark—and thinking about how the effects of IP protection 
differ in different contexts.  So the distinctions among small and 
large businesses are touched on; they are addressed in IP 
scholarship generally.  But the idea of having a single Symposium 
to think about that particular issue with regard to the different 
forms of IP and in different contexts is, I think, a terrific idea that’s 
going to make for an interesting program. 
So as not to delay that program any longer, I’m going to turn 
the podium over to Kathy Strandburg.  As I said, Kathy is a 
visiting professor here this year from DePaul University College of 
Law and is teaching patent law and Internet law.  We have been 
thrilled to have her here this semester. 
PROF. STRANDBURG: Thank you, Mark.  I’ll just add my 
thanks to the journal for putting this program together, and 
particularly to Anthony Rizzo, who I think has done a fabulous job 
in getting the speakers and getting the panels together. 
I’m going to begin.  My job here is to provide just a little bit of 
introduction to the topic of this panel.  The topic of the panel is 
“Cross-Licensing and Injunctions—the Interplay Between Big 
Business, Small Business, and Non-Practicing Inventors.”  Another 
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name we might give to this panel is “What’s Happening After the 
eBay v. MercExchange1 Case?” 
That’s going to be the focus of the panelists.  Just to provide a 
little introduction to that, I’m going to give you a little background 
information on the eBay case.  I have a couple of PowerPoint 
slides to go with that. 
The eBay v. MercExchange case is a Supreme Court case that 
came out in 2006, so it’s now a couple of years old.  We think this 
is a good time to look at what has been happening, what the 
implications of the case have been so far, and to think a little bit 
about, in the future, where things are going. 
The eBay case involves eBay—I’m sure everyone knows what 
eBay is—and a company called MercExchange, which owned a 
patent which was on—and here I’m quoting from a description of 
it in the Supreme Court’s opinion—“an electronic market designed 
to facilitate the sale of goods between private individuals by 
establishing a central authority to promote trust among 
participants.”2 
There was a jury trial in the case, and the jury determined that 
eBay infringed and that the patent was valid.3  This is where our 
story begins, because the eBay v. MercExchange Supreme Court 
case has to do with the question of remedies: What happens after 
you find out that the patent is infringed and valid? 
The district court in this case declined to grant an injunction.4  
The reasons that the district court gave for declining to grant an 
injunction were that MercExchange had shown through its prior 
behavior that it was willing to license its patents and that it was a 
patentee that had not itself commercialized its invention.5  The 
district court decided, in a sort of categorical way, that for those 
reasons, there would be no injunction. 
 1 eBay Inc. v. MercExchange, L.L.C., 547 U.S. 388 (2006). 
 2 Id. at 390. 
 3 Id. at 390–91. 
 4 Id. at 391. 
 5 Id. at 393 (citing MercExchange, L.L.C. v. eBay, Inc., 275 F. Supp. 2d 695, 712 
(E.D. Va. 2003)). 
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The Federal Circuit reversed on the grounds that there was 
basically a general rule—I think all of us who either taught or 
practiced patent law prior to eBay were quite familiar with this 
general rule—that if there is infringement and validity, you get a 
permanent injunction.6  In fact, in my patent class, when I first 
started teaching it, I spent probably five minutes on injunctions, 
because there wasn’t really much to say.  Now, of course, it’s a big 
topic, and I spend at least one class on it, because of this case. 
What happened at the Supreme Court? At the Supreme Court, 
the entire court agreed that there should be no general rule favoring 
injunctions7—disagreeing with the Federal Circuit.8  The entire 
court also agreed, however, that the district court had not gotten it 
right, that there was no categorical rule against an injunction just 
because you were a non-practicing entity who was willing to 
license your patents.9  The Supreme Court concluded that in patent 
litigation, as elsewhere, the determination as to whether or not to 
grant an injunction should be a discretionary, equitable 
determination by the court based on the traditional four-factor 
test:10 (1) asking about whether there was irreparable injury; (2) 
asking about whether there was an inadequate remedy at law; (3) 
looking at the balance of hardships to be expected if an injunction 
is or is not issued; (4) looking at questions of whether the 
injunction would be against the public interest.11 
Interestingly, the unanimous opinion was very short, and there 
were two concurrences that had rather different takes on the main 
opinion. 
Justice Roberts wrote a concurrence in which he highlighted 
the long tradition of granting injunctions in patent cases, noted that 
this historical practice was relevant and should be considered in 
looking at what to do in the future,12 and also made the point that 
 6 Id. at 393–94 (citing MercExchange, L.L.C. v. eBay, Inc., 401 F.3d 1323, 1338 
(Fed. Cir. 2005)). 
 7 Id. at 391, 394. 
 8 Id. at 394. 
 9 Id. at 393. 
 10 Id. at 394. 
 11 Id. at 391. 
 12 Id. at 394–95. 
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although there is discretion, discretion is not whim and this long 
tradition of granting injunctions is significant.13 
Justice Kennedy had a very different perspective on the 
opinion.  He emphasized the importance of the context, the 
technological and economic context, in which the court would be 
considering whether to give an injunction.14  He discussed the 
concern about the use of injunctions as a bargaining tool, as a way 
to be able to charge what he called exorbitant fees, in cases where 
a patent covered only a small part of a project15—what is 
sometimes called the holdup problem.  He also mentioned as a 
consideration what he called “the potential vagueness and suspect 
validity” of some business-methods patents.16 
So it was quite clear that Justice Roberts saw this case as 
making a minor correction in doctrine, probably without much 
significance, whereas Justice Kennedy—and both of these justices 
were joined by others—saw this case as possibly making a very 
significant difference because of the changes in technology and 
economics that had happened in recent times. 
So that’s where we stand.  That’s all I’m going to say.  Our 
panelists are going to address what has happened since then and 
some of the many questions left open by the Supreme Court: 
Under what circumstances are we going to end up denying 
injunctions?  What do we do if an injunction is denied?  What 
other kinds of remedies are we going to use?  Particularly of 
interest to us here in this panel are what kinds of effects this 
possible denial of injunction has on the business and legal 
strategies of patentees and potential infringers. 
I’m going to introduce each panelist individually as he or she 
speaks, so they can each have appropriate attention. 
Our first panelist is Lisa Ferri, who is a partner in the law firm 
of McDermott, Will & Emery here in New York and is a member 
of the Intellectual Property, Media, and Technology Department 
and also serves on the firm’s Life Sciences Steering Committee.  
 13 Id. at 395. 
 14 Id. at 395–97. 
 15 Id. at 396. 
 16 Id. at 397. 
VOL19_BOOK4_PATENT PANEL 11/16/2009  5:28:54 AM 
2009] PATENT: CROSS-LICENSING & INJUNCTIONS 933 
She focuses her practice on patent and other intellectual property 
litigation.  As you have already heard today, she’s an adjunct 
professor of law here at Fordham, for which we are very grateful. 
She received her J.D. from Seton Hall Law School and served 
as an editor on the Law Review during that time.  She then served 
as a law clerk to Chief Judge Edward Re of the U.S. Court of 
International Trade.  She has a lot of experience in trial, appellate, 
and International Trade Commission (or “ITC”) practice, from 
which we will benefit when we hear her remarks today. 
With that, I’m going to turn it over to Lisa. 
MS. FERRI: Good morning. 
In the past two and a half years, since the eBay decision has 
come down, practitioners in this field have shown great interest in 
the district courts’ application of this decision.  It has been watched 
very closely.  It has had a significant effect on how companies 
approach patent litigations and how they deal with suits and 
whatever attendant settlement or licensing negotiations may flow 
from that.  It has certainly also had a great impact on practitioners 
in terms of advising clients. 
Certainly it has to do with how we might approach our clients, 
depending on their business model.  For instance, if it is a 
manufacturing company or if it is a non-practicing entity or a 
research institute, all of that will go into the approach taken by the 
company when it comes to the application of eBay. 
As Professor Strandburg said, prior to eBay, the injunction was 
fairly automatic if your patent was found to be infringed and valid.  
That’s no longer the case.  There is little consensus among the 
district courts on how to apply eBay, but certainly there are a 
number of trends that we have seen.  For instance, competition 
between the parties, loss of market share, or loss of reputation may 
weigh in favor of granting the injunction, whereas if you are a non-
practicing patentee and you have a licensing program, that may 
weigh against it in the district court’s view. 
If the patented invention is a small component of a larger 
product, that also can weigh against an injunction, whereas any 
ability to calculate losses may go in favor of the injunction. 
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One of the primary factors we have seen is competition 
between the parties.  Generally speaking, if they are competitors, 
an injunction will be issued.  The fact that they are competitors 
weighs heavily on the factors of the irreparable harm and the 
inadequacy of monetary damages, as we see from a few of the 
cases I have shown just as examples.  For instance, in the Becton 
Dickinson17 case in Delaware, the court looked at the loss of 
market share of the patentee in issuing the injunction.18  In 
Amgen,19 similarly, the fact20 would counsel for an injunction 
because there would be great loss of market share, profits, and 
ability to maybe license exclusively to the patentee.21 
As a comparison, just a few examples of the opposite scenario.  
In Advanced Cardiovascular System,22 even though they were 
competitors, the court found that, specifically, the way the patentee 
had delineated the market, on this particular product they were not 
competing head to head, and the court did not issue an 
injunction.23  In the Innogenetics24 case, there was an injunction, 
 17 Becton Dickinson & Co. v. Tyco Healthcare Group LP, No. 02-1694, 2008 WL 
4745882 (D. Del. Oct. 29, 2008). 
 18 Id. at *3–4. 
 19 Amgen Inc. v. Ariad Pharm., Inc., No. 06-259-MPT, 2008 WL 4487910 (D. Del. 
Oct. 3, 2008). 
 20 In Amgen, the U.S. District Court for the District of Delaware issued a declaratory 
judgment in favor of Amgen regarding its claims for non-infringement of U.S. Patent No. 
6,410,516 (the “516 Patent”). Id. at *3.  The case focused on the Amgen drug Enbrel, 
which the court found “acts outside of cells, rather than inside the cells.” Amgen Inc. v. 
Ariad Pharm., Inc., 577 F. Supp. 2d 695, 700 (D. Del. 2008). This tended to show non-
infringement of the 516 Patent. Id. at 701–02.  
 21 Ariad now seeks reinterpretation of the asserted patent claims by the Court of 
Appeals for the Federal Circuit. See Chris Reidy, Ariad Wins Its Request to Appeal 
Patent Ruling, BOSTON GLOBE, Oct. 6, 2008, http://www.boston.com/business/ 
ticker/2008/10/ariad_wins_its.html.  Ariad is the exclusive licensee of the 516 Patent, 
which was developed by research groups in Boston. See Ariad Files Claim Against 
Amgen and Wyeth Alleging Infringement of NF-(kappa)B Patent by Enbrel® and 
Kineret®, BUSINESS WIRE, Apr. 13, 2007, available at http://www.genengnews.com/ 
news/bnitem.aspx?name=15625265.  Since Ariad is the exclusive licensee of the patent 
in question, issues of market share could be relevant on appeal, particularly in light of the 
Becton Dickinson opinion, which focused on market share and was decided a few weeks 
after Amgen. 
 22 Advanced Cardiovascular Sys., Inc. v. Medtronic Vascular, Inc., 579 F. Supp. 2d 
554 (D. Del. 2008). 
 23 Id. at 562. 
 24 Innogenetics, N.V., v. Abbott Labs., 512 F.3d 1363 (Fed. Cir. 2008). 
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rable harm.  
 
which was then reversed because at the district court level there 
was a future component to the damages royalty payment given to 
the patentee, and the Federal Circuit found that that really showed 
that there was no irrepa 25
Where there is no competition between the parties, often there 
will not be the injunction issued.  This goes to what we call the 
patent trolls,26 the non-practicing entities.  An example of this is 
Paice v. Toyota,27 which is a fairly well-known case where Paice 
just licensed the technology.28 
There was an exception to this in the past few years, the 
CSIRO29 case, in which the court did issue an injunction and really 
looked to the fact that although the patentee didn’t practice, they 
were a research entity and the court felt that there would be loss of 
possible funding, there would be a problem in getting researchers, 
loss of reputation, and that a compulsory license just would not 
function to make the patentee whole in that situation.30  The 
injunction was issued.31 
In light of eBay, a patent holder should consider moving to the 
International Trade Commission as a forum, especially if an 
injunction is deemed to be necessary.  A complainant or patentee 
in the ITC may obtain an exclusion order or a cease-and-desist 
order against any imported goods that are made outside the U.S.32  
This is not subject to the eBay factors.  This is actually quite 
popular, because you will not have to go through the test of the 
 25 Id. at 1380. 
 26 “The term ‘patent troll’ was coined in the late 1990s by Peter Detkin, then assistant 
general counsel at intel, to refer to patent owners who hide under bridges they did not 
build to pop out and demand money from surprised passers-by.” Mark A. Lemley, Are 
Universities Patent Trolls?, 18 FORDHAM INTELL. PROP. MEDIA & ENT. L.J. 611, 613 n.2 
(2008). 
 27 Paice LLC v. Toyota Motor Corp., 504 F.3d 1293 (Fed. Cir. 2007). 
 28 Id. at 1303. 
 29 Commonwealth Scientific & Indus. Research Org. v. Buffalo Tech. Inc., 492 F. 
Supp. 2d 600 (D. Tex. 2007), aff’d in part, vacated in part, 542 F.3d 1363 (Fed. Cir. 
2008). 
 30 Id. at 604. 
 31 Id. at 608. 
 32 19 U.S.C. § 1337 (2006). 
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four elements there.33  Although the ITC does often look at a 
public-interest factor, it’s extremely rare.34  There are probably 
fewer than a handful of cases where they have failed to exclude an 
imported product based on public interest. 
It is necessary, however, to establish that there is a domestic 
industry for the patented invention.  For this reason, you may 
wonder if this would apply, then, to a non-practicing entity.  But 
under the statute, which is 19 U.S.C. § 1337, a non-practicing 
entity can turn to the ITC for injunctive relief if they establish that 
domestic industry exists, meaning that the patented invention is 
exploited in the U.S., and you can show this through licensing.35  
This is a forum that a troll or a non-practicing entity can benefit 
from. 
Another benefit is that you can have a district court action 
proceeding simultaneously.  So you can file suit in the ITC for the 
injunction, file simultaneously in the district court, and have the 
damages component going.  Because of this, we have seen a 
dramatic increase in ITC filings since the eBay decision.  In my 
own practice, I have seen in the last two years that this has become 
a very popular forum for non-practicing entities, because that 
threat of the injunction really does push the settlement and the 
possibility of licensing, along with the fact that this very rapid pace 
also puts some pressure, as do the companion district court cases. 
Since the eBay decision, we would expect to see increased 
litigation, certainly as the chances of an injunction decrease.  This 
would apply, of course, for the non-practicing entities’ situation, 
because there is certainly less incentive to settle then.  Among 
competitors, the threat of counterclaims sometimes tempers this 
threat of injunction, and many large companies, like the Ciscos and 
 33 eBay v. MercExchange, 547 U.S. 388, 391 (2006) (“A plaintiff seeking a permanent 
injunction must satisfy a four-factor test . . . (1) that it has suffered an irreparable injury; 
(2) that remedies available at law, such as monetary damages, are inadequate to 
compensate for that injury; (3) that, considering the balance of hardships between the 
plaintiff and defendant, a remedy in equity is warranted; and (4) that the public interest 
would not be disserved by a permanent injunction.”). 
 34 19 U.S.C. § 1337 (2006). 
 35 Id. § 1337(a)(3) (“[A]n industry in the United States shall be considered to exist if 
there is in the United States . . . substantial investment in its exploitation, including 
engineering, research and development, or licensing.”). 
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Oracles, have large patent portfolios that they really use 
defensively in this situation. 
For the non-competitors, really there has been a shift in the 
balance of power here.  There may be a thought of why not risk the 
litigation, because the worst-case scenario is maybe that if you 
lose, you pay this royalty. 
For some companies in this post-eBay world, it seems that the 
accused infringer really is benefiting, because the patentee may not 
be able to exclude with any certainty.  If there is no injunction, 
what does the patentee receive in that case?  We have seen that 
certain of the district courts have basically looked to past 
infringement damages and then used that going forward to put in 
place a royalty.  In the Paice decision, which both parties appealed 
to the Federal Circuit, the Federal Circuit remanded this, with the 
thought in mind that the royalty rate that was set from the past 
infringement really would not be the appropriate undertaking by 
the parties.36 
If there is a thought of something other than an increased 
royalty payment, what should it be—if it’s thought that the past 
infringement damage is not sufficient?  The court in the CSIRO 
decision felt that just going on the past infringement is not 
sufficient, because you are not really valuing the patent and its 
worth today, and you are not taking into any consideration maybe 
non-monetary licensing terms that should be available to the 
patentee.37 
Post-eBay, we certainly see cross-licensing for certain 
industries as being very popular.  For instance, in the 
semiconductor/computer software industries, where they have 
amassed a large patent portfolio, this can be used both offensively 
and defensively.  You find in this particular industry that products 
can be covered by hundreds of patents, so you can easily be an 
inadvertent infringer.  For that reason, having this kind of 
defensive portfolio is very important. 
 36 Paice LLC v. Toyota Motor Corp., 504 F.3d 1293, 1315 (Fed. Cir. 2007). 
 37 Commonwealth Scientific & Indus. Research Org. v. Buffalo Tech. Inc., 492 F. 
Supp. 2d 600, 606 (E.D. Tex. 2007). 
VOL19_BOOK4_PATENT PANEL 11/16/2009  5:28:54 AM 
938 FORDHAM INTELL. PROP. MEDIA & ENT. L.J. [Vol. 19:925 
For the pharmaceutical companies, in contrast, cross-licensing 
really is not a popular option.  Injunctions are very important to 
that business.  Part of this flows from the fact that research and 
development in this area is extremely costly, and you may have a 
patent there that covers a pharmaceutical product that is worth 
billions of dollars.  So injunction is really what you are seeking. 
The cross-licensing really only works as a solution if the 
patentee will face a comparable threat from its target.  In the 
instance of the non-practicing entity, there’s really not much 
interest in the cross-licensing, because they are not really subject to 
that threat.  So in those scenarios, really, what we see is that 
litigation is going to be the option that they will be pursuing. 
Thank you. 
PROF. STRANDBURG: Thank you very much, Lisa. 
Our next panelist is Jack Griem, who is a Partner at Milbank in 
the Intellectual Property Group of the Litigation Department, here 
also in New York.  He also concentrates his practice on litigation, 
but also is involved with license and technology-development 
agreement negotiation and other kinds of intellectual property 
issues involved in corporate and finance transactions. 
He is a member of the Pharmaceutical Issues Committee of the 
Intellectual Property Owners’ Association and a former member of 
the Committee on Patents and the Committee on Trademarks and 
Unfair Competition of the Bar Association of the City of New 
York. 
He received his J.D. with honors from Hofstra University Law 
School, where he was on the editorial board of the Law Review. 
With no further ado, I’ll turn it over to Jack Griem. 
MR. GRIEM: Thanks, everyone, for coming.  I look forward to 
discussing these issues with you after we have done our 
presentations. 
Today I just have a few slides that are generated to provide 
some thoughts for further discussion and also, perhaps, a minor-
note counterpoint to Lisa’s presentation. 
I have tried to take a look at the effects of eBay and the issues 
raised by the panel topics from the view of the smaller company.  
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By that I mean a company that has a smaller portfolio.  It may or 
may not be practicing—the company, that is to say, may or may 
not be making a product—but it is certainly a company, like almost 
all patent owners, in the business of technology and research and 
technology development.  It also implies a company that has fewer 
resources.  In my experience as a practicing attorney doing a lot of 
litigation, from a practical perspective, you do have to consider the 
resources of the parties in thinking about what kind of strategy 
they will follow. 
I think that smaller companies, even in a post-eBay 
environment, have a lot of advantages that go a long way to 
outweighing the shift in the presumption of the injunction that 
came with eBay.38  In litigation, especially litigation that only 
involves a few patents, the parties spend a lot of time focusing 
resources and trying to pick apart or build up those particular 
patents.  From experience, patent quality is built during 
prosecution.  A smaller company that focuses on a fewer number 
of patents is, I think, inevitably, more likely, going to get a higher 
quality out of their patents, and that will show up in the litigation.  
They will be able to assert them with more confidence, and I think 
that shows. 
Larger companies inevitably end up having to manage larger 
portfolios.  Decisions are made on an overall basis, with less focus 
on particular patents.  That ends up playing out in the way they 
negotiate cross-licenses.  They look at the whole portfolio and they 
pick a few patents as representative, rather than looking at each 
patent individually and trying to assess its value. 
I think that the market is now such that small companies and 
individual inventors should not necessarily fear litigation.  They do 
not have the hammer of the injunction that used to come with the 
presumption that the Federal Circuit had created and which the 
Supreme Court took away in the eBay decision.39  But I think with 
good counsel and some creative thinking, a small company can tell 
a story of competition that would merit an injunction and tell a 
story of innovation that will get the judge on their side. 
 38 eBay v. MercExchange, 547 U.S. 388, 393–94 (2006). 
 39 Id. 
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I think the most important thing that came out of the eBay 
decision was a return to the courts of the power of equity.  What 
that means is that the judge is now much more in control of 
fashioning a remedy.  The courts have an inherent power to do 
that.  The statute expressly refers to the principles of equity in 
empowering courts to grant injunctions.40  I think that what that 
means is that a small company, which I think is going to have a 
story to tell and may, in fact, be owned by the inventor, can usually 
tell a pretty good story in equity to the court that has the power to 
grant the injunction.  I think that’s important. 
The market has developed in a way, as we all know, that ends 
up providing funding for litigation to support patents that are 
deemed to have value.  If a small company does have a real 
invention that has been adopted industry-wide, even if they are not 
practicing, they can usually find a way to bring the case. 
Larger companies have a greater risk in litigation.  Even if the 
litigation value is assessed only on the value of the royalty that is 
going to be paid, either as the result of a judgment or as a result of 
a settlement, the time and the cost that goes into defending the 
litigation is a factor that works in favor of the smaller company.  
The small company probably just simply doesn’t have the same 
number of documents and witnesses and so can use rules, 
particularly rules in some of the courts in this country, the patent 
rules, in order to impose a really high burden on the defendant to 
make them focus early on prospects for settlement. 
Of course, the risk of patent countersuit is small.  They may not 
have a product at issue, and if they do, it’s less likely that the other 
side has a patent that would implicate that product. 
In assessing whether or not to settle, obviously the threat of 
injunction was always a big factor in whether or not to settle, 
whether or not to take a case to trial.  I think a really good example 
of this is the settlement that was achieved in the RIM litigation that 
was brought by NTP.41  That, I think, is one of the best and last 
examples of the power of the injunction.  They had won, and while 
 40 35 U.S.C. § 283 (2006). 
 41 See NTP, Inc. v. Research In Motion, Ltd., 418 F.3d 1282 (Fed. Cir. 2005); Carl 
Tobias, Blackberry Litigation: Lessons Learned, 28 NAT’L L.J. 34 (2006). 
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the patents were even being reexamined, the judge was clearly 
done with the case.  He was about to implement that presumption, 
and so the parties ended up deciding that settlement was the right 
option.42 
That wouldn’t be the case today, I don’t think.  But you still 
have the risk.  Until you get farther along in the litigation, you still 
have to litigate the merits.  You still have to litigate the reasonable 
royalty.  Jon can tell us that that can vary widely and there are a lot 
of factors that go into that.  So I think you still end up with the real 
possibility of settlement, even if the injunction isn’t a sure thing. 
The CSIRO case teaches us that there are some good strategies 
that the smaller company can take in order to tell a story of 
entitlement to an injunction based on competition and based on 
harm, intangible harm, to their economic prospects.  As I said, 
every company, even a small company, even an individual 
inventor, is involved in the business of research.  So the principle 
in that case applies.  Even a large company that is not really 
competing yet in a particular market can argue that they are 
researching in an area where the other company is selling a 
product. 
Also the law allows you to take advantage of what your 
licensees are doing, if the licensee is willing to participate in the 
suit.  Several cases have found that you can’t take advantage of 
harm to your licensee if they are not in the suit, but if they are in 
the suit, even as a passive participant, you can piggyback off the 
harm that would come to them in getting an injunction. 
That’s all I have prepared in my slides.  We can talk about this 
more later. 
PROF. STRANDBURG: Thank you very much. 
Our final panelist is Jonathan Putnam, Vice President of CRA 
International.  He may tell you a little bit about what they do.  He 
has a Ph.D in economics from Yale and is an expert in intellectual 
property, industrial organization, applied microeconomics, 
 42 Peter J. Pizzi, Patent Injunctions: The Effect on the Public Interest of ‘NTP v. RIM’, 
235 N.Y. L.J. 5 (2006). 
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technological change, and antitrust, and has served as an expert 
witness in many, many different fora. 
He is also a research associate at the Institute for Policy 
Analysis and for four years, served as the Ontario Research and 
Development Challenge Fund professor of the law and economics 
of intellectual property at the University of Toronto, in their Centre 
for Innovation Law and Policy. 
As I mentioned, he has served as an expert witness in many 
kinds of cases, including patent infringement, trade secret, 
antitrust, contract actions, in front of virtually any forum you can 
imagine, and also previously taught at Vassar, at Columbia 
University, both in the law school and the business school, at Yale, 
and at the Boston University Graduate School of Management. 
He also managed to get here, despite the vagaries of Amtrak 
from Boston.  So we are very appreciative of that.  I’ll turn it over 
to him. 
MR. PUTNAM: Thank you, Katherine. 
There was some discussion among the panel members about 
who would represent large versus small companies on the panel.  
So I thought, as an empirical person, I would ask for you to rank 
companies according to their size, since I asked myself, do I 
represent large companies or small companies?  I don’t know what 
that means. 
So rank the following companies by size: Tyson Chicken, 
JCPenney, or General Motors. 
JCPenney is much bigger than General Motors right now, 
based on market capitalization.  General Motors is in a neck-and-
neck fight with Tyson Chicken as to which is larger.  Depending 
on how things go on Capitol Hill, General Motors either pulls 
ahead or falls behind.  They had a good day yesterday with the 
senators, and they pulled slightly ahead of Tyson Chicken.  If you 
are following stocks to bet, General Motors may be the next big 
company.  You might want to look at that for a growth stock. 
I bring this up because I don’t actually care about the size of 
companies; I care about getting the right market price.  Jack talked 
about the NTP litigation, which I would not style, as an economist, 
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a small company versus a large company, although that’s true.  I 
would say the reason why that was a problem was because the 
price that was reached for the technology in question was vastly 
out of line.43  As a result of the possibility of an injunction, the 
small company exerted enormous leverage.44 
At the end of my talk, we are actually going to go back to this 
and I’m going to evaluate the NTP case, in light of the things I 
want to discuss. 
So my first magic act today is to try to convince you of 
something that you probably think is not true.  It’s sort of cliché in 
litigation that when you are arguing about public policy in favor of 
settlement, people say that it’s good to have certainty in litigation; 
companies crave certainty and they don’t like an uncertain 
environment; it was good, whether you agree with eBay or not, that 
the Supreme Court actually weighed in and settled some things; we 
need to have certainty. 
So the first thing I want to convince you of is that certainty is 
not always a good thing.  Let me give you an example. 
Suppose we are playing a game called Matching Pennies.  In 
the Matching Pennies game, the way it’s going to work is, you and 
I are just going to pull out a penny.  We are going to turn it over.  
If both coins are heads or if both coins are tails, you get to take my 
penny, if they match.  But if the coins are heads and tails or tails 
and heads, then I get to take your penny.  So the question is, what 
are you going to do?  You could, believing in certainty, say, “I’m 
going to take out my penny and I’m going to play heads.  It’s good 
to have certainty, and so I’m playing heads every single time.”  
But, of course, if I know you are going to play heads every single 
time, then my best strategy is to play tails every single time, and 
until you figure this out, I will keep taking your penny from you, 
because you are playing a certain strategy. 
What is your optimal strategy?  Your optimal strategy is to flip 
your coin and show me whatever comes up.  Then the best I can do 
 43 Sheri Qualters, Patent Review Overhaul Draws Praise: A Process Once Viewed as 
Risky May Help Avoid Costly Delays and Suits, 30 NAT’L L.J. 8 (2007). 
 44 BlackBerry Battle Ends in $612.5m Settlement, 28 NAT’L L.J. 12 (2006). 
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is take it half the time by flipping my coin.  So you pursue 
something called a mixed strategy. 
“What does that have to do with anything?” you might ask.  
That’s a good question.  What it has to do with injunctions is that if 
you know that you are certainly going to face an injunction or if 
you know that you are certainly not going to face an injunction, 
then that affects your incentives in the way you play the game.  If 
you know that you can get an injunction against somebody, guess 
what?  You have an incentive to become a patent troll and file suits 
that have little merit, but a small chance of an enormous payoff.  
That’s how I would characterize NTP.  If you know that you are 
not going to face an injunction, what are you going to do?  You are 
much more likely to infringe and say, “You know what?  The 
worst that can happen to me is, I’ll take the deal that I’m being 
offered right now.  So I’ll take this guy to court, try to bleed him 
dry, and if the judge imposes anything, he’s going to impose the 
offer that I’m facing today.” 
Those are two kinds of opportunistic behavior that you want to 
avoid.  What you want is for the court to have enough discretion 
and flexibility to say, “We might very well award an injunction in 
this particular case, and you can’t prove that we’re not going to.”  
That deters people, when they think there is some possibility of a 
very bad outcome either way.  We might not get one or we might 
get one, depending on what happens. 
So the first point is that incentives actually really matter.  I’m 
going to talk to you about various factors that arise within the 
context of the ordinary litigation that courts should look to to make 
injunctions less likely or more likely. 
We just talked about the Matching Pennies example.  The point 
of it is that an automatic injunction or the removal of the automatic 
denial of an injunction removes uncertainty, and that leads to bad 
incentives.  You want people to face uncertainty; they behave 
better. 
What’s the second point?  The second point is that if there is an 
established royalty for the patent—how many times has this 
happened to you?  You go into litigation, the plaintiff says, “I want 
$500 million for your infringement,” and then you get them to 
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produce all their prior license agreements on the same technology, 
and Georgia-Pacific45 says that these prior agreements are 
irrelevant,46 and so they have settled with twenty other defendants 
for $2 million to $5 million.  But from you, they want $500 
million, and that’s what they are going to tell the jury. 
What’s the problem with that?  The problem with that is that all 
the defendant’s prior settlements are inadmissible.  So they can go 
before the jury and say, “This patent is worth $500 million,” even 
though there are twenty people who have decided otherwise and 
these guys have signed a deal with them. 
I have real data from a case, where I have shown that 
settlements follow a linear trend relative to market share.  We have 
the plaintiff’s demand, $535 million for a settlement that is 
predicted to be about $4 million.  What should this fact pattern tell 
you?  Let’s assume that the case goes to trial and that the defendant 
actually loses, instead of settling in advance.  What should this tell 
you about the prospects for an injunction? 
If you can prove that there is an established royalty for the 
patent, you should not get an injunction.  The market price has 
already been decided, number one, and number two, the plaintiff 
has shown a willingness to license.  In that case, if there is an 
established royalty, no injunction, or it should be less likely. 
You should also ask, though, at this point the purely legal 
question: should the settlements continue to be inadmissible at the 
injunction phase of the trial?  I would say not. 
Also, if the case goes to trial and the damages award markedly 
exceeds the rate at which the plaintiff has settled with other 
defendants, I would say that also argues against an injunction, 
because the plaintiff is, in effect, being overcompensated.  We 
allow the jury to decide this.  We allow the jury not to see the 
inadmissible settlements.  But if you get stuck with $300 million 
when everybody else is paying $3 million, you probably should not 
also be enjoined. 
 45 Georgia-Pacific Corp. v. U.S. Plywood-Champion Papers, Inc., 446 F.2d 295 (2d 
Cir. 1971). 
 46 Id. at 298. 
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Next, suppose the defendant proves that it has a non-infringing 
alternative.  Under the Grain Processing47 case, what that means is 
that the court should look to the next best alternative and the cost 
of switching to it as a measure of the reasonable royalty.48  If I’m 
using a particular process and the next best process would cost me 
one percent more and it yielded just as good a product, then the 
royalty that I’m willing to pay for the right to use that process is 
about one percent.  It’s not rocket science. 
Suppose you have that alternative available and you can show 
that it was available to you throughout the period, and suppose 
that’s what the jury awards you, one percent.  Should you get an 
injunction?  Yes, you probably should.  The reason why is because 
the defendant says, “There’s a non-infringing alternative.  I can 
switch.”  If the defendant has already said, “I can switch,” then 
that’s a good reason to hope the defendant is not bluffing and say, 
“Okay, switch.” 
The entire-market-value rule: if the patent covers the entire 
market value of the product, an injunction should be more likely.  
Clearly, that’s not the case in NTP v. RIM.49  But the critical point 
here is that if you issue an injunction, there is no significant loss of 
intellectual property to the consumer.  The main intellectual 
property is the asserted patent, and so you are enforcing the 
asserted patent and not losing the benefits of all the other 
intellectual property.  If you enjoin BlackBerry’s, guess what?  
There are 1,000 patents in that BlackBerry.  You are enforcing the 
rights of one and causing people to lose the benefits of the other 
999. 
Suppose the plaintiff says, “Look, you would have settled with 
us for a fully paid-up royalty.  You would have paid us $20 
million.  That’s our reasonable royalty,” based on whatever the 
argument is.  Suppose the jury awards $20 million.  Should you get 
an injunction?  No.  If you paid for a fully paid-up royalty, you 
should get a fully paid-up license, which means over the life of the 
patent.  That should be per se, in my opinion. 
 47 Grain Processing Corp. v. Am. Maize-Prods. Co., 185 F.3d 1341 (Fed. Cir. 1999). 
 48 Id. at 1346–51. 
 49 See NTP, Inc. v. Research In Motion, Ltd., 418 F.3d 1282 (Fed. Cir. 2005). 
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Something that is slightly more gray: suppose the plaintiff 
demands a royalty that’s based on sales projections that occur after 
the trial.  For example, I’m in a case right now where the plaintiff 
is demanding a very high royalty based on sales that a defendant 
has not yet made, but expects to make.  Averaged over the twenty 
years of projections, the device is supposed to be very profitable, 
but as of today, it’s not profitable.  If the jury awards that high 
royalty rate based on those high projections over the lifetime of the 
product and not limited to the damages period, which ends at trial, 
then it should be less likely that you would get an injunction.  In 
effect, you are paying for sales that occur in the future. 
Standards: what do standards mean? Standards are valuable, 
whether they are private or public.  A standard simply means that 
you are able to organize intellectual property and coordinate it in 
such a way that you produce a product that is more useful.  Intel 
organizes its intellectual property when it produces a 
semiconductor chip, and telecommunications bodies organize 
intellectual property when they create public standards so that our 
cell phones can all talk to each other. 
If you enjoin a patent under these circumstances, you hold up 
access to a whole slew of intellectual property for the sake of 
enforcing the rights of one.  Under these circumstances, an 
injunction should be less likely, because the whole point of the 
patent system is to promote progress,50 and you are denying 
progress if the amount of intellectual property that you are keeping 
off the market is so much greater than the amount whose rights you 
are enforcing. 
Two things that might appear to be non-economic parts of a 
case, but actually are not: if there is a laches defense—obviously, 
if there is a successful laches defense and there is no infringement, 
it’s not an issue.  If a defendant has a good laches defense that 
fails, however, that might be enough to establish that there is a 
reliance interest in the intellectual property in question, and that 
would make it less likely that an injunction should issue. 
 50 See, e.g., Am. Plastics Cos. v. Gits Molding Corp., 182 F.2d 1000, 1005 (7th Cir. 
1950). 
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The principle here is you want to reward an innovation; you 
don’t want to reward holdup behavior or opportunistic behavior.  
You don’t want somebody to invest in technology, market it, sell 
it, and then eight years later, all of a sudden they find, after they 
have sunk their investment, that there is one little piece of 
intellectual property whose permission he needs to get.  What will 
happen, if you face an injunction, is that you will pay a lot of 
money not to lose that investment, and what you are rewarding is 
delay, not the innovation itself.  Don’t do it. 
If you can prove willful infringement, that shows that the 
plaintiff ex ante knew about the invention, chose to infringe, and 
that shows an incorrect evaluation of the alternatives.51  You don’t 
want to reward opportunistic behavior by a defendant who says, 
“What the hell?  Let me take a flyer on it and see what happens.” 
Injunctions are thought of as being binary things, but one thing 
that you might want to do to allow the market to exercise some 
more control is to say, “I’m going to impose an injunction, but I’m 
going to impose it after a certain delay that gives the defendant the 
chance to do something else, like, for example, design around the 
invention.”  That allows the parties to sit down and actually 
negotiate over the future use of the invention, knowing that the 
patent is, in fact, valid, enforceable, and infringed, and to arrive at 
a price. 
Then the question becomes, how long should you give the 
party to design around?  Five years is probably too long; five days 
is probably too short.  But this is what the judge decided in the 
Broadcom v. Qualcomm52 litigation.  Qualcomm could sell its 
existing generation of phones and the injunction went into effect 
after a period of months. 
One question is, what’s the delay?  The second question is, 
when should the defendant begin thinking about the alternatives?  
Obviously, showing up in court the date the Federal Circuit hands 
down its decision on appeal and saying, “Gee, we haven’t really 
thought of an alternative.  Can we have some time?” is not 
credible. 
 51 See Jeanne Fromer, Patent Disclosure, 94 IOWA L. REV. 539, 587–88 (2009). 
 52 Broadcom Corp. v. Qualcomm Inc., 2009 WL 684835 (S.D. Cal. Mar. 12, 2009). 
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How would you look at these things?  I’m just going to wrap 
up by saying, let’s think about NTP v. Research in Motion.53  The 
BlackBerry is, in effect, a private standard.  RIM has organized a 
tremendous amount of intellectual property, both its own and 
others, all of which was going to be held up by the enforcement of 
a single patent right.54  That would argue against an injunction. 
Was the NTP patent the source of the entire market value of the 
BlackBerry?  Clearly not. 
Were the damages awarded high relative to comparable 
agreements?  Enormously high.55  I have worked against the other 
expert, NTP’s expert, on two occasions, and—you can’t argue with 
success, but you can argue with the truthfulness of the testimony.  
There is no relationship to economic reality. 
Does it reflect the value of the next best alternative?  Probably 
not. 
Then you can go through the checklist—willfulness and laches 
and other things like that that are not economic considerations. 
But again, if you had gone through in this fashion, you would 
have decided that an injunction is much less likely to issue in the 
NTP case, not simply because it’s a non-practicing entity, but 
because of considerations that emerged in the course of discovery 
and trial. 
I think I’m done. 
PROF. STRANDBURG: Thank you very much. 
At this point, what we want to do, after those very thought-
provoking presentations, is move into a phase of discussion. 
I want to start just by seeing whether any of the panel members 
have questions they want to address to one another, points they 
want to make in response to the things that the other panelists said.  
 53 NTP, Inc. v. Research In Motion, Ltd., 418 F.3d 1282 (Fed. Cir. 2005) 
 54 Id. at 1289–91. 
 55 See Garret Barton, Permanent Injunctions: A Discretionary Remedy for Patent 
Infringement in the Aftermath of the Ebay Decision, 16 U. MIAMI BUS. L. REV. 1, 12–13 
(2007).  The district court awarded NTP, Inc. monetary damages totaling $53,704,322.69.  
NTP, Inc., 418 F.3d at 1292. 
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Then we will move on.  I have a few questions for discussion, and 
we are very interested in hearing all of your questions as well. 
So I’ll start by asking if anyone wants to respond to what the 
other panelists said. 
[No response]. 
Since the panelists are completely happy with each other’s 
presentations, let me ask a couple of questions.  In the meanwhile, 
you all out there should be thinking about the questions that you 
would like to ask.  We won’t spend too much time before we get to 
you. 
I guess one of the questions I want to ask, just in terms of your 
experience since eBay, is whether you have seen—and you 
mentioned the Qualcomm example—what kinds of things you have 
seen courts doing in order to craft remedies, now that we don’t 
have the automatic injunction.  What are they doing?  Are they 
doing ongoing royalties?  Are they having parties come back? 
Not only what are they doing, but what might courts do to craft 
more creative remedies, now that they have more flexibility? 
MS. FERRI: I would say that—kind of twofold.  First, just to 
step back and look at what remedies the parties are hoping for and 
looking toward, I think, has created some, perhaps, creative 
thinking on the part of some companies.  I know I have seen 
certain non-practicing entities now try to recast themselves as 
being research institutes, so that they can fall under this CSIRO 
decision.56  If an injunction is really important to you, I talked 
about going to the ITC.  If that’s not an option and you are in a 
U.S. district court, I think you have to be kind of creative in terms 
of how you describe yourself and how you put the evidence 
forward to the court to try to get the remedy you want. 
I think part of this—it’s difficult to tell, because all of the 
district courts are looking at these factors.  In these two years, we 
have seen, I think, all kinds of different decisions, and not 
necessarily consensus.  Some of the district courts are holding 
separate trials after judgment to then determine what the proper 
 56See Microsoft Corp. v. Commonwealth Scientific & Indus. Research Org., 2009 
WL 440608, at *2 (E.D. Tex. Feb. 23, 2009). 
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payment is going forward, this future aspect of the license.  I think 
Judge Rader said in his concurrence in Paice v. Toyota57 that he 
thought it should go back to the parties and the parties should sit 
down and come up with a determination, a negotiation, of what the 
license should be.58  But, of course, depending on their positions 
and what strengths and weaknesses they have, if they don’t do that, 
it has to go back to the district court, and you may end up with the 
compulsory license. 
So I think at this point it’s hard to tell where you will end up.  
You have to be creative about it and be a little fluid in what 
arguments you put forward. 
MR. GRIEM: I have some doubts that the idea that one of the 
things the court can do is to impose a compulsory license that is 
really consistent with the fundamental idea of an injunction.  An 
injunction is—a hallmark is that there is irreparable harm.59  I have 
argued that the fact that the royalties have already been determined 
and there are reasonable predictions about future sales means that 
you shouldn’t get an injunction, because now you don’t have 
irreparable harm.  You have reparable harm, and you can figure 
out what the payment should be. 
What do you all think about whether that can be squared with 
the idea of imposing a compulsory license with the terms that 
come with that kind of license? 
MS. FERRI: I think there are a lot of companies that are—that 
very eventuality of a compulsory license seems inherently unfair.  
Maybe, practically speaking, what shakes out is that if you are a 
competitor and you have the irreparable harm, you are going to get 
the injunction, so you are just talking about situations, maybe, 
where there are non-practicing entities, so that the license seems 
fair.  But I think in a circumstance where you feel that patent rights 
give you the right to exclude, the compulsory license just doesn’t 
seem to be the right outcome. 
 57 Paice LLC v. Toyota Motor Corp., 504 F.3d 1293, 1317 (Tex. 2007) (Raider, J., 
concurring). 
 58 Id.  
 59 See Savage v. Gorski, 850 F.2d 64, 67 (2d Cir. 1988). 
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At that point, you feel like you have an adjudicated infringer, 
that there is willful infringement.  There is some aspect of this—
crafting a royalty just from past infringement doesn’t take into 
consideration, I think, the situation you reach after adjudication of 
infringement. 
MR. PUTNAM: One of the things that I’m confused about in 
this whole situation is, do you want to imagine the parties 
bargaining—let’s suppose that the judge says, “Go try to work this 
out,” and they come back and say, “We can’t work this out.”  Do 
you say, “Let’s take advantage of all the information we have 
today,” and, in effect, do like you do in a reasonable royalty, in a 
hypothetical negotiation, and imagine the parties come to an 
agreement based on today’s information?  Or do you simply go 
back and say, “No.  We’re going to adhere to the deal that you 
would have made back at the time that infringement began?” 
In other words, what is it about the injunction that allows you 
to take advantage of all the information that has accumulated since 
the time of initial infringement?  That is going to yield sometimes 
vastly different terms, sometimes terms that are vastly more 
favorable to the defendant and other times vastly more favorable to 
the plaintiff, than would have occurred at the time of the initial 
hypothetical negotiation. 
Without having thought about it more, it seems like there ought 
to be equitable reasons why someone should examine the 
assumption that we are going to bargain as of today.  Maybe that’s 
right, but I don’t think that should be an unexamined assumption. 
Then the question becomes—I think Jack’s point is well-
taken—are there actually sales projections or are there harms that 
can’t be measured?  For example, you may be competing for brand 
identification or something like that or a network effect, where it 
is, in effect, a winner-take-all market.  I have a five percent 
probability of being a monopolist in this market if I can start right 
now.  My projected sales projections are small, but I have a small 
chance of being very large.  It’s not really fair to say, “Well, we’re 
going to give you a two percent royalty,” or something like that, 
because the harm that you are facing is that you have a competitor 
that otherwise you wouldn’t. 
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So I feel that the critical distinction is whether the plaintiff can 
point to harms that are non-monetary.  That goes without saying.  
But you really need to be able to say—here’s where an economist 
can help you—what are the things that are damaging to me, apart 
from the loss of sales, that are going to occur if I allow the 
defendant into my business? 
PROF. STRANDBURG: It seems to me that a couple of things 
that come up when you start thinking about awarding damages or a 
royalty rate at the time when you already have the infringement in 
the past—it’s different from just the reasonable-royalty calculation. 
You have to think a little bit more about what the terms of the 
license would have been.  How long would the license have gone 
on?  Normally you don’t think about that if you are thinking about 
past damages.  Would there have been in the license terms a 
chance of renegotiating rates or, depending on sales, would this 
and that have happened? 
So it seems like it really complicates the idea of the 
hypothetical negotiation.  I’m just kind of curious what judges are 
doing about that.  Are some of them just trying to come up with a 
lump sum so that they don’t have to have the parties back in front 
of them every year or two years?  What are they actually doing? 
MS. FERRI: I think, probably, in terms of just the way 
litigations flow, in terms of how long it takes you to get to a 
judgment, we are just starting to see that now.  I think this is 
something that is going to kind of unfold over the years.  At this 
point there are a number of decisions in terms of the remedies that 
have been crafted when an injunction hasn’t been put in place.  
You have this compulsory license that has a reasonable-royalty 
aspect to it and some lump-sum payments.  I don’t think we have 
seen enough to really see any really creative outcomes of it.  I 
think some of the questions are more to what kind of evidence the 
court is looking to and if they in some instances have a second trial 
after the first one, in terms of determining, forward, what the 
damages are going to be or that monetary remedy. 
I think that’s where maybe you see the creative kind of aspect 
of it, because, as you say, there is so much more evidence that’s 
going to go in at that point in time, when they are an adjudicated 
infringer. 
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MR. GRIEM: I think courts are taking the discretion that eBay 
gave them,60 and it’s really empowering them to try to help the 
parties do that present negotiation that Jon mentioned.  Instead of 
doing it when the infringement began—and you didn’t know that 
you were infringing, but now you do—they can hold a hearing, 
give the parties time to talk, and then make suggestions that leave 
that uncertainty there,61 so that, as Jon mentioned in his talk, you 
have a situation where the parties have to try to think about the 
worst case and the best case and at least have a chance to come to 
some resolution.  The deadline of the hearing where an injunction 
might issue, I think, certainly spurs them to either buy that 
certainty that comes with the settlement or take their chances. 
If they decide they are both stuck in their positions and they 
either do or don’t think an injunction is going to issue, the 
requirement of irreparable harm, I think, means that you could end 
up with pretty much a binary choice: there’s an injunction 
prohibiting use of the invention in a particular field or the judge 
says, “There is a way for you to figure out the economic value.  
This is not irreparable harm.  So I can’t issue an injunction.  What 
you are going to have to do is, having found this product to 
infringe, in a few years, towards the end of the patent, you are 
going to have to have another litigation where you quantify the 
damages that should have been quantifiable now if you had been 
reasonable.  But I don’t have the power to impose a license at this 
point.” 
MR. PUTNAM: One thing that I think is happening that is a 
mistake is some variation of the following fact pattern: suppose 
that the plaintiff has licensed with firm A for a five percent royalty.  
At trial, the jury sees that evidence and says the defendant should 
pay a five percent royalty also.  Then, when it comes to an 
injunction, the court says, “Well, gee, five percent seems to be the 
royalty in the marketplace.  The jury decided that.  The plaintiff 
has agreed to it.  I’m just going to impose five percent.” 
I think we have seen things that are roughly like that, and that’s 
erroneous.  The reason why is because, prior to trial, the patent was 
 60 eBay Inc. v. MercExchange, L.L.C., 547 U.S. 388, 394 (2006). 
 61 Id. at 396–97. 
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not valid and infringed.  It had some expectation of being valid and 
infringed.  But at trial, it is proven to be valid and infringed.  So if 
you are bargaining over a valid and infringed patent, the rate 
should go up. 
For example, suppose that the five percent royalty that was sort 
of the market benchmark was arrived at based on the following 
negotiation pattern: the parties agree that if the patent is valid and 
infringed, the royalty should be ten percent.  But they think there is 
only a fifty percent chance that it’s valid and infringed, so the 
settling party, party A, says, “I’ll pay you five percent, because I 
think there is only a fifty percent chance that your patent is valid.”  
So the plaintiff says, “Okay, it’s a deal.” 
What should happen under those circumstances at trial is that 
you should now back out the uncertainty that was present in the 
initial negotiation and award a royalty rate of ten percent, not a 
royalty rate of five percent, because the factor that was present in 
the market negotiation is no longer present post-trial. 
This obviously becomes a source of tremendous argument, 
because then the question becomes, how likely was it, in fact, that 
the patent was invalid or not infringed, and how is that uncertainty 
reflected in the original negotiation? 
At trial, the plaintiff is looking for the highest royalty rate post-
trial they can get, so they want to say, “Your Honor, we think that 
five percent royalty rate that we agreed to initially should be 
converted to a twenty percent royalty rate.”  The logical 
implication of that is to say to the plaintiff, “Oh, does that mean 
you only thought there was a one-fourth chance your patent was 
valid and infringed?  You just got lucky here at trial?  Is that what 
you mean?” because that’s the implication of what they are saying. 
Then the defendant might say, “Well, Your Honor, they agreed 
to five percent in the marketplace.  We think that we should only 
pay eight percent.”  Then you can say to the defendant, “Oh, are 
you saying that there was a very high likelihood that this patent 
was valid and infringed?  That’s not what I heard from you last 
week in your closing arguments when you said that this patent was 
the trashiest thing you had ever seen.” 
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So the parties have opposing incentives at the point of the 
injunction to argue about the market evidence that would support 
an increase in the royalty rate going forward.  It makes it quite 
complicated for the court to sort out how much to bump up the 
market rate to reflect the resolution of the validity questions. 
PROF. STRANDBURG: It seems to me that there is also a 
question of whether the court should do that.  It depends on 
whether you think, as you were mentioning before, that the 
appropriate thing is to look at what the negotiation would have 
been before the litigation or after the litigation.  I don’t think we 
really know, at least from a legal point of view.  Maybe from an 
economic point of view, there are ideas about that.  Which is the 
appropriate time to be looking at? 
MS. FERRI: I could see, too, that if we are talking about doing 
this—although it seems fairly—now it has issues of judicial 
efficiency.  If you are having another trial later on, after the patent 
term is ready to expire and you are looking back, what other things 
are people going to enter into as evidence—“this is willful 
infringement, and I think that this rate should be trebled”?  You 
can imagine that there are going to be a lot of factors, to say that 
the market has changed, and now this is much more valuable.  
There is going to be a lot of thought given to this, and a whole new 
set of evidence will be put in by the parties. 
PROF. STRANDBURG: I’m going to ask one more question 
and then we are going to open it up to questions from the audience. 
We have seen this one example—or at least there is one 
example—of the sort of Qualcomm approach, where we say, 
“Okay, you didn’t know you were infringing, but now you do.  So 
we will give you a certain period of time to fix it, and if you don’t 
fix it by then, there will be an injunction.”62 
My question is, are there situations in which that wouldn’t be a 
good approach?  Or should we think that that should be the usual 
approach?  Are there particular situations in which that approach 
 62 See Qualcomm Inc. v. Broadcom Corp., 539 F. Supp. 2d 1214, 1220 (S.D. Cal. 
2007). 
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would be problematic?  That avoids a lot of these valuation 
problems, clearly, too.  That’s the thing in its favor. 
MR. PUTNAM: I actually favor that approach, because it 
converts something that is a binary choice into something that is 
almost a continuous choice.  In other words, if the injunction issues 
at infinity, then that’s like no injunction.  As you come forward 
from infinity to the injunction issues tomorrow, then that’s your 
regular, straightforward injunction.  So it allows you to convert 
something that is a 0,1 variable into a continuous variable, and you 
can express a lot of discretion in that choice. 
The other thing that it does is, when faced with a valid and 
infringed patent and the prospect of an injunction, a lot of 
defendants will say, “Okay, we need to find a way around this 
technology,” and so it actually operates to stimulate more R&D 
and investment in other technology, which is one of the main 
purposes of the patent system.  So it’s actually consistent with the 
larger goal, which is to find another way to skin this cat so I don’t 
have to pay this slimy plaintiff the amount that she is asking. 
So I actually think that it is, in principle, quite a good idea.  
The real question becomes—as I said, there are two evidentiary 
issues.  One is, what is the product cycle?  If you think that Intel’s 
chip infringes some patent, the plants that are designed around 
these chips cost billions of dollars to build, and the next generation 
is not going to be built for four years.  If you say an injunction is 
going to issue in four years, that essentially renders the patent 
worthless.  But that’s the product cycle. 
On the other hand, it’s going to issue in three years.  That 
means that in three years Intel has to build a new plant and incur a 
five billion dollar cost a year early.  That’s an enormous amount of 
expense. 
So you can’t say, “Well, it should really issue at three years 
and ten months, because we want to give the guy twenty million 
dollars,” or something like that.  That sounds ridiculous. 
The other question is, what’s the onus on the defendant to start 
thinking of ways around this?  You can sort of play a game of 
chicken with the court and say, “No, no, no, no, we’re not going to 
think about alternatives.  We have no alternatives until we get to 
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the injunction phase.”  Presumably, you have been thinking about 
this case for several years.  You should be thinking about what 
your next best alternatives are.  If the defendant walks into the 
court after three years of litigation and says, “Guess what?  We 
have no alternatives,” unless it’s sort of an Intel case, I would say, 
“Maybe this is a more valuable invention than you are really 
willing to admit, because you can’t think of a way not to use it.” 
MS. FERRI: I just add, thinking about this while we are 
discussing it, it’s interesting because that aspect of the alternative 
and the designing around is a very normal practice within the 
International Trade Commission.  It’s very standard within the 
proceedings there, because the respondents know that they are 
facing certain injunction if the patent is found valid and 
infringed.63  So during the course of the proceedings there, very 
often you find the respondents actually come to the court with 
design-arounds.  You can provide the administrative law judge 
with your design-around as part of the proceedings, and the judge 
will take a look at it and determine whether that is infringing or 
not.64  So by the end of this proceeding, you already know what’s 
going to happen, that you can hit the market, so to speak, with the 
new product, if you are going to be hit with this exclusion order. 
MR. GRIEM: I think that really illustrates the difference in the 
administrative sort of remedy that is embodied in the ITC,65 where 
you have this certainty of process that focuses attention on dealing 
with the business after the inevitable might happen, while a court 
has more equitable discretion to fashion a remedy.  They have to 
first find irreparable harm, but then, in fashioning a remedy, they 
have to consider the public interest.66 
Before eBay, it used to be that the only kinds of cases where 
you had a chance of not getting an injunction were in medical 
 63 19 C.F.R. §§ 210.50–.51 (2008). 
 64 BARRY L. GROSSMAN, PATENT LITIGATION STRATEGIES HANDBOOK 63 (BNA Books 
2000). 
 65 See U.S. Int’l Trade Comm’n, Intellectual Property Infringement and Other Unfair 
Acts, http://www.usitc.gov/intellectual_property (last visited Nov. 14, 2009). 
 66 See eBay, Inc. v. MercExchange, L.L.C., 547 U.S. 388, 391 (2006) (citing Amoco 
Prod. Co. v. Gambell, 480 U.S. 531, 542 (1987); Weinberger v. Romero-Barcelo, 456 
U.S. 305, 311–13 (1982)). 
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device or product cases, where the health of the public would 
suffer if an injunction issued, because the plaintiff couldn’t meet 
the market demand and the public would thereby suffer, because 
there wouldn’t be enough medicine or product to serve them. 
But now you have a situation where every company can say, 
“Here are all the things that are going to inconvenience me if you 
issue an injunction.  I have to do this design-around that I have 
been putting off.  I have to do a recall.  I have to explain to my 
customers.  They’re going to think that I am not as smart or good 
as I was before.  But then they will be deprived of the benefit of 
my product.  I have tried so hard to give them the benefit of this 
product.” 
The Federal Circuit’s reaction to all that used to be, “Well, you 
took a bet.  You lost it.  This is what happens.  You suffer the 
injunction.  We are not going to even let you burden us with all of 
that.” 
But now the court has to do all this.  That’s why they are 
holding separate hearings in order to hear through all this.  
Sometimes it ends up being persuasive.  I think it looks like a 
benefit to the public when you do that, if you don’t issue an 
injunction, because you still get the product.  But in the end, it just 
rewards companies for being big and stupid and slow, or at least 
pretending to be big and stupid and slow.  They have managed to 
shift the cost of their infringement back onto the party that has 
been founded, invented, and has been infringed. 
MR. PUTNAM: You mean small companies like General 
Motors, right? 
PROF. STRANDBURG: Let’s open it up and see what 
questions we have from the audience. 
QUESTION: I think it was Jonathan who mentioned that prior 
settlements or licenses were not admissible.  Does the panel have 
an idea as to how to correct that, if they think that’s something that 
is worth achieving? 
MR. PUTNAM: The question was, is there some way of 
changing the general rule that settlements to litigation are not 
admissible in subsequent litigation? 
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I taught at a law school, and I know enough to know that that’s 
a question of evidence.  So not being a lawyer, I’m going to refuse 
to answer it. 
PROF. STRANDBURG: Does anyone else want to take that 
one? 
MS. FERRI: Changing the rule on that I think is difficult.  It’s 
not really something you can change.  What you have to do is find 
a way to work around it and deal with it.  That would be in terms 
of the negotiations that you are going to have.  In terms of whether 
you can get that before the judge or the jury, you won’t be able to, 
but I think that you can take that into consideration in how you are 
dealing with the case. 
That’s probably a lot of what we were talking about throughout 
the panel in terms of the negotiation stance of either party and that 
that will certainly be an issue that can kind of force settlement and 
have something to do with what kinds of terms you get in your 
licensing. 
PROF. STRANDBURG: I do think that the eBay case opens up 
some of these evidentiary questions for argument.  You can always 
argue that after eBay, the damages questions that courts are facing 
are now different.  Therefore, different evidence is now relevant, 
and you make an argument for whatever evidence you want.  It 
may be that courts might be willing to hear those arguments and 
see what they are doing a little bit differently than they did before 
eBay. 
In other words, any new decision like that is a wedge to make 
an argument that maybe should have been successful before.  You 
can always try it again.  So I do think that there is an opening to 
make those arguments. 
How the Federal Circuit, in the end, will respond to it, who 
knows? 
MR. GRIEM: I think you have hit on something very 
important.  The rule is set up to protect juries from being misled.  
The hypothetical negotiation is supposed to happen with this 
assumption that the patent is valid and infringed, and how you are 
having a negotiation from that point.  The settlements based on 
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litigation don’t have that assumption in them.  That’s why they are 
excluded as irrelevant and prejudicial. 
But when you have the hearing about the remedy, the 
injunction remedy, now the jury isn’t there.67  Now it’s the court 
exercising discretion, and the court can take whatever evidence it 
wants into consideration.68 
MR. PUTNAM: I can’t resist—this is coming from an 
economist, so it’s actually legal content-free. 
There are lots of policy reasons for not including settlements of 
litigation.  But you could imagine the defendant asking that the 
plaintiff be estopped from arguing, for example, that there is no 
established royalty.  It’s just not true that everybody else in the 
industry hasn’t signed up to license these patents on terms that are 
vastly different from the ones that the plaintiff is claiming.  You 
might ask for a motion in limine to prevent the plaintiff’s expert 
from testifying as though that were not the case.  Even if you 
didn’t want to produce the agreements themselves, there might be 
a way of redacting them or summarizing them, or at least 
preventing the plaintiff from misrepresenting their existence, 
without actually disclosing them.  That might be a way in. 
As an economist, it frustrates me, because it’s data.  It’s good 
data.  No, it’s not comparable to the situation you are in, but it’s 
the best data you have.  You should work with it and adjust it, the 
way you do all other data. 
QUESTIONER: In the example you gave, the market data was 
around $4.4 million. 
MR. PUTNAM: Yes. 
QUESTIONER: But they were awarded $535 million. 
MR. PUTNAM: The question was, in the example that I gave, 
based on the defendant’s market share, the predicted settlement 
 67 See FED. R. CIV. P. 65(a)(2). 
 68 See David V. Radack, Injunctions in Patent Infringement Cases, http://www.tms.org/ 
pubs/journals/JOM/matters/matters-9712.html (last visited Nov. 14, 2009) (“Balancing 
the harms of the plaintiff and defendant is very fact specific and is basically a way for the 
court to exercise its discretion in granting or withholding a preliminary injunction.”). 
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was about $4.4 million.  The plaintiff was asking for $535 million.  
The case didn’t actually go to trial.  But that was the disparity. 
QUESTIONER: What I was going to say is, if they did get the 
$535 million, could you not get an injunction against— 
MR. PUTNAM: Right now, as far as I know, there is no legal 
connection between the size of the damages settlement and the 
prospect for an injunction.  So you could get both, which just 
seems to me like vastly double-counting. 
PROF. STRANDBURG: That’s a question, whether a judge 
might take that into account in determining—it’s not one of the 
four factors,69 but whether the judge might nonetheless take that 
into account in determining whether to grant an injunction. 
MR. PUTNAM: If it were a close case—and that’s not a close 
case—the plaintiff might say, “That does not fall within the four-
factor test.  That was then; this is now.  We are talking about 
retrospective versus prospective remedies.  You can’t contaminate 
the two.”  I think that’s wrong, but somebody needs to decide that. 
PROF. STRANDBURG: Yes, exactly. 
QUESTION: The last speaker talked about patent trolls.  After 
eBay, have you seen a reduction in the number of patent trolls or 
lawsuits brought by patent trolls, or patent-holding companies? 
MR. PUTNAM: From the point of view of actually computing 
data, it’s hard to define a patent troll.  For example, within my 
company, when we are looking at whether to take a case or not, I 
have an internal checklist of fifteen factors that make it more or 
less likely that the plaintiff is a troll, and you sort of score on that 
scale.  It’s hard to say. 
I think the overall number of patent cases is down from two 
years ago or three years ago. 
MS. FERRI: Slightly, yes. 
MR. PUTNAM: Slightly, yes.  There hasn’t been a vast 
reduction.  It’s hard to say that eBay has caused the trolls to 
disappear.  I don’t think that’s true. 
 69 See eBay, 547 U.S. at 391 (identifying the four relevant factors). 
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MS. FERRI: I don’t think so.  At least in my practice, I don’t 
think so.  I agree that it’s really hard to categorize every one that is 
a non-practicing entity as a patent troll—with that pejorative, let’s 
say.  As I mentioned, I have seen this movement of some of the 
cases into the ITC in order to benefit from the idea that you will 
get the injunction. 
But I think, generally speaking, those cases are going strong, 
and eBay hasn’t necessarily diminished them.  I think it has just 
changed, perhaps, how you approach it.  We mentioned with the 
CSIRO that some of these companies now are trying to do a bit of 
research or have a research arm, subsidiary, and put some 
resources into that and just trying to maybe recast themselves a bit. 
MR. GRIEM: Just a final note.  I don’t think you can trust the 
numbers.  The classic troll case has twelve defendants.  You sue an 
industry.  Is that one case or is it twelve? 
MR. PUTNAM: I think you are just now getting to the point 
where cases that hadn’t been filed by the time of the eBay decision 
are getting to the point of being tried and going to judgment. 
The question you are really asking is, how has it changed 
incentives?  It’s not, how did it change cases that were already 
pending when eBay was handed up?  I think it is too early to tell, 
based on cases that are filed after eBay, whether—I haven’t seen 
any change in behavior, but it’s too early. 
MR. GRIEM: My response to that would be that every plaintiff 
has a different story, and I think it’s misleading, and ultimately not 
very useful, to try to create a category called “troll.”  There are a 
number of well-known patent-holding companies or individual 
inventors—people like Lemelson or others—that big business has 
considered to be trolls, a drain on their innovation.  But I can tell 
you that every one of them, if you talk to them, has a great story to 
tell about innovation and developing intellectual value and talking 
about the history of the American inventor in the garage.  It’s a 
very powerful story, and I don’t think that it’s really productive to 
say that there is this group and we need to find strategies. 
MR. PUTNAM: And some of those stories are even true. 
MS. FERRI: I think where you may see some of that is if you 
examine the various amicus briefs that were filed in the eBay v. 
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MercExchange case.70  You go through them and you can see that 
there was a real—you may not be able to pick out, based on the 
company, where they are falling.  You have a company, for 
instance, like Qualcomm, who you think of in the past as maybe 
being part of manufacturing, but they are very big in just 
development and licensing now.  They actually were more in line 
with MercExchange,71 where Microsoft and all these other 
companies were falling more in line with eBay in terms of the 
sides they were taking in the case.72  I would imagine in a lot of 
these companies that there was a lot of internal discussion on 
which side they would support in that case.  You find a little bit of 
both in terms of this inventive process.  You find that everywhere. 
PROF. STRANDBURG: I heard recently of someone who was 
trying to do something like this, by trying to look at the effects on 
share values of publicly traded companies that filed amicus briefs 
in Supreme Court cases.  Their work is unpublished.  But it sounds 
to me, so far anyway, as though the results are pretty 
inconclusive—for what that’s worth.  You can keep a lookout for 
that paper, which will come out, I assume, at some point. 
QUESTION: Jonathan, I have a question regarding the 
standard type of case that you talked about.  Research in Motion 
 70 See, e.g., Brief for General Electric Company et al. as Amici Curiae Suggesting 
Affirmance, eBay Inc. v. MercExchange, LLC, 547 U.S. 388 (2006) (No. 05-130); Brief 
for Technology Patents & Licensing, Inc. et al. as Amici Curiae Supporting Respondent, 
eBay Inc. v. MercExchange, LLC, 547 U.S. 388 (2006) (No. 05-130); Brief for the 
United States as Amicus Curiae Supporting Respondent, eBay Inc. v. MercExchange, 
LLC, 547 U.S. 388 (2006) (No. 05-130); Brief of American Innovators’ Alliance as 
Amicus Curiae in Support of Petitioners, eBay Inc. v. MercExchange, LLC, 547 U.S. 388 
(2006) (No. 05-130); Brief of the American Bar Association as Amicus Curiae 
Supporting Respondent, eBay Inc. v. MercExchange, LLC, 547 U.S. 388 (2006) (No. 05-
130); Brief of Various Law & Economics Professors as Amici Curiae in Support of 
Respondent, eBay Inc. v. MercExchange, LLC, 547 U.S. 388 (2006) (No. 05-130). 
 71 See, e.g., Brief of Amici Curiae Qualcomm Incorporated and Tessera, Inc. in 
Support of Respondent, eBay Inc. v. MercExchange, LLC, 547 U.S. 388 (2006) (No. 05-
130). 
 72 See, e.g., Brief Amici Curiae of 52 Intellectual Property Professors in Support of 
Petitioners, eBay Inc. v. MercExchange, LLC, 547 U.S. 388 (2006) (No. 05-130); Brief 
of American Innovators’ Alliance as Amicus Curiae in Support of Petitioners, eBay Inc. 
v. MercExchange, LLC, 547 U.S. 388 (2006) (No. 05-130). 
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had a portfolio of intellectual property.73  I assume you are an 
expert in valuation or an economic expert? 
MR. PUTNAM: I do do that, yes. 
QUESTIONER: Drilling down past the economic value of the 
patent if it’s valid and infringed, how would you further drill down 
into what component that comprises of the portfolio to make the 
BlackBerry? 
MR. PUTNAM: I actually know exactly the answer to that 
question.  I can cut to the chase and tell you that you are feeling 
very sleepy— 
QUESTIONER: No.  I have a CPA. 
MR. PUTNAM: Oh, we can have lunch, then, and keep each 
other awake. 
I’ll give you the thirty-second answer to this question.  I 
developed a method for exactly these types of cases.  I testified 
against the expert who was NTP’s expert.  So I prepared it 
basically for him and people like him.  I testified against him in 
February. 
The method is called “Count, Rank, and Divide.”  What it 
comes down to is saying, let’s find the set of patents that are 
embodied in a particular device, which turns out to be quite 
difficult sometimes.  But let’s assume you can do that.  Let’s rank 
them according to importance.  We don’t know what their 
importance is exactly, but you can use various economic indicators 
as a proxy for importance— 
QUESTIONER: Would part of that be whether or not there are 
existing licenses, so that if one is not licensed at all but is 
exclusively owned and is said to be exploited, that might be the 
most important one, versus ones that are cross-licensed as part of 
normal standards for other devices? 
MR. PUTNAM: There are various criteria.  I try to keep it 
simple, because that data is missing as to whether something is 
licensed and under what terms. You have to start looking at 
 73 See, e.g., U.S. Patent No. 7,362,898 (filed July 26, 2007); U.S. Patent No. 7,369,089 
(filed July 13, 2007); U.S. Patent No. 7,375,658 (filed June 22, 2007); U.S. Patent No. 
7,432,831 (filed Apr. 17, 2007); U.S. Patent No. 7,334,952 (filed Apr. 10, 2007). 
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contracts.  There are sixteen patents licensed or it’s a cross-
license—it’s hard to say what it means by “a licensed patent.” 
I actually use a version of patent citations as a way of ranking 
something, which, the economic literature shows, is correlated 
with value.  Once you have established that there are, say, 200 
patents in a BlackBerry and that the asserted patent ranks 50th of 
those 200 patents, let’s say, the question is, can you find a way, 
based on the economic literature, to say what the share of total 
value is of the 50th patent?  The answer is yes.  I published on 
this.74  I wrote my dissertation on it.  There are about eight people 
that have published on this.  It’s a very small niche of the 
economic literature. 
But you can actually sit down and figure this out.  You say the 
50th-ranked patent out of 200 can’t be worth more than X percent 
of some pie.  Then you say, what is the pie?  Is it all of the 
BlackBerry’s profits over the past fifteen years or the next twenty 
years or whatever?  You decide the pie and then divide it according 
to these shares and award this 50th-ranked patent its share. 
Typically, if you do that, unless it’s like the number one patent, 
you are going to get a very small share of total value, because it 
has to be split with 199 other ones. 
I can send you an email that will describe it in more detail. 
PROF. STRANDBURG: Do we have another question?  
Mark? 
PROF. PATTERSON: I have a question that sort of follows up 
on that or is related to that.  It seems to me, though, that to do that, 
you have to really decide—we don’t think of the patents in the 
licensing context, in the valuation context, as having some sort of 
inherent value based on their technology.  We think of them as 
having some value based on what they can do in the market.  
Suppose Research in Motion has nine patents that you think are 
also valuable.  To decide whether NTP is asking too much, you 
have to look at those and decide whether there are non-infringing 
 74 See, e.g., Jonathan Putnam, Jean Lanjouw & Ariel Pakes, How to Count Patents and 
Value Intellectual Property: The Uses of Patent Renewal and Application Data, 46 J. 
INDUS. ECON. 405 (1998). 
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alternatives to—you would have to have a meaty trial on each 
piece—which is great for you, if you are the expert—on each piece 
of Research in Motion’s technologies, as well as NTP’s. 
I just don’t know how that wouldn’t get too unwieldy—in 
addition to the fact that we have this view, in the patent-pooling 
context and in others, that if each element is needed, each element 
is essential in some ways.  So doing it this way is a little bit 
circular, in the sense that you are deciding that the value is based 
on components.  But that’s really the problem.  NTP would say, 
“No.  Any patent that is needed is 100 percent of the value.  Each 
of them that is needed is 100 percent of the value.”  You are just 
saying, “No, that isn’t the way it is.” 
But I think the Federal Circuit—in the Phillips75 case, for 
example—says that is what it is: if any patent is needed, you are 
sort of entitled to extract the whole value of the invention out of 
that.76 
So I think your economic approach seems to go contrary to the 
Federal Circuit’s legal one. 
MR. PUTNAM: I’m going to say two things.  I find this topic 
absolutely fascinating.  It’s also not what we are talking about on 
this panel. 
Since this is a law school, I should give a legal answer.  The 
legal answer is that I’m trying to implement Georgia-Pacific77 
factor thirteen,78 which is to credit the invention and separate the 
value of the invention from all the other inputs that are added by 
the infringer.79  Georgia-Pacific factor thirteen actually implies 
some kind of apportionment, and that’s what I’m trying to do.  I 
would say that’s the legal basis for doing it. 
 75 See Phillips v. AWH Corp., 415 F.3d 1303 (Fed. Cir. 2005) (en banc). 
 76 See id. at 1323 (rejecting the idea that the claims of a patent describing a single 
embodiment must only be limited to that specific embodiment). 
 77 Georgia-Pacific Corp. v. U.S. Plywood Corp., 318 F. Supp. 1116 (S.D.N.Y. 1970). 
 78 Id. at 1120 (considering one of the factors in determining a reasonable royalty in a 
patent license to be “[t]he portion of the realizable profit that should be credited to the 
invention as distinguished from non-patented elements, the manufacturing process, 
business risks, or significant features or improvements added by the infringer.”). 
 79 Id. 
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As to how it works mechanically, I really will bore everyone 
here— 
PROF. STRANDBURG: Not everyone. 
PROF. PATTERSON: It’s interesting that the Federal Circuit 
at times seems to ignore that.  That was what the Eastern District 
of Pennsylvania in Georgia-Pacific80—generally, the Federal 
Circuit sort of goes along with it.81  But sometimes it seems to say, 
“No.  We’re going to take a somewhat different approach.”82 
MR. PUTNAM: Patent damages jurisprudence is smack-dab in 
1875. 
PROF. STRANDBURG: Do we have other questions? 
(No response) 
I think we had a fantastic panel.  I thank our panelists again. 
We will adjourn until 11:30. 
 
 80 Id. 
 81 See, e.g., Interactive Pictures Corp. v. Infinite Pictures, Inc., 274 F.3d 1371, 1386 
(Fed. Cir. 2001) (affirming the Georgia-Pacific factors as providing ample evidenciary 
support for a resulting royalty rate); TWM Mfg. Co. v. Dura Corp., 789 F.2d 895, 899 
(Fed. Cir. 1986) (upholding a lower court’s determination of royalty based on subtracting 
the value of infringing devices from the infringer’s net profit). 
 82 See, e.g., Imonex Servs., Inc. v. Munzprufer Dietmar Trenner GMBH, 408 F.3d 
1374, 1380 (Fed. Cir. 2005) (rejecting appellant’s claim that factor thirteen was pertinent 
to a calculation of damages); Fromson v. Western Litho Plate & Supply Co., 853 F.2d 
1568, 1578 (Fed. Cir. 1998) (refusing to apportion based on the Georgia-Pacific factors). 
